cellengineer

Thanks Richardsonj, We will probably follow a similar path for validation. We have started by comparing to our standard reagents on the bench, and wanted to be sure we were getting useful data. I think we will also need to do some with the new Echo reagents.

For validating the instrument vs. yourABO/D- tube testing, did you use the same Echo anti-sera as on the instrument? Is this a requirement?

We are looking for a protocol to do neonatal transfusion on an emergency basis. Does anyone know where we can find some direction on this topic, so we can develop the capability to respond to a rare event for us?